-
Most children presenting for care related to fever at two Tanzanian outpatient clinics had acute respiratory infections. Malaria accounted for "only" 11% of diagnoses and typhoid fever for 4%.
-
Posaconazole oral suspension (Noxafil® oral suspension, Merck) has been, for several years, indicated for treatment of orophayngeal candidiasis as well as for prophylaxis of invasive Aspergillus and Candida infections in patients at risk. Posaconazole delayed-release tablets (Noxafil® delayed-release tablets, Merck) were recently FDA-approved for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients 13 years of age and older.
-
A national survey of parents found that information from the CDC about vaccines and adverse facts may not be effective in correcting parental misperceptions. Some attempts to heighten parental awareness about vaccine-preventable diseases and vaccine safety may actually be counterproductive.
-
-
Not a week goes by where I do not see at least one or two newly diagnosed cases of syphilis and not just in my HIV+ MSM patients. Syphilis is beginning to appear in young heterosexuals as well.
-
Autologous CD4+ T-cells modified to delete CCR5 by Zinc-finger nuclease (ZFN) were infused into 12 HIV-infected patients. Cells survived in the circulation of patients and provided some control of viral replication and immune reconstitution after interruption of antiretroviral therapy.
-
TB rates among pre-school aged children in the United States are 32 times higher in foreign-born children and six times higher in U.S.-born children with at least one foreign-born parent, compared to U.S.-born children with U.S.-born parents.
-
Hepatitis C virus (HCV) infection is an important global health issue that affects approximately 184 million people. Conventional therapy for HCV with interferon and ribavirin is associated with high rates of virological failure and severe side-effects.
-
While hospice use steadily increased and deaths in the hospital declined, intensive care unit care in the last month of life increased, according to two recent studies.
-
The association between oral contraceptive use and ovarian or breast cancer in BRCA1 or BRCA2 mutation carriers are qualitatively similar to associations reported in the general population. Oral contraceptive pill use is inversely associated with ovarian cancer risk. However, it is also associated with a modest, but not statistically significant, increased risk for breast cancer. The analysis was unable to provide conclusive recommendations as to their use as preventive measures given these and other unmeasured risks. However, oral contraceptive pills appear safe for contraception in this population.